ReviewCurrent cardiology reports2012

Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT.

Toni Terry et al.PubMed ↗Publisher ↗

No numbers read from the abstract.